Literature DB >> 11736709

Palliative treatment of hepatocellular carcinoma by chemoembolization.

A Poyanli1, I Rozaneş, B Acunaş, S Sencer.   

Abstract

PURPOSE: The efficacy of transcatheter arterial chemoembolization (TACE) and the correlation between iodized oil uptake pattern and tumor response were investigated in cases with inoperable hepatocellular carcinoma (HCC).
MATERIAL AND METHODS: TACE, using sequential intra-arterial doxorubicin, mitomycin, iodized oil and gelatin sponge particles, was used to treat patients with inoperable HCC localized to the liver. One hundred and two patients (aged 16-80) were treated in this manner from 1995 to 2001. The objective response was determined by sequential CT. Iodized oil uptake pattern as well as the relationship between uptake pattern and tumor response was evaluated in each case.
RESULTS: The one-year survival rate was 46%. Tumor response was found to be better in cases with dense and peripheral iodized oil uptake in comparison to those displaying scarce and patchy iodized oil uptake.
CONCLUSION: TACE is an efficient and safe palliative treatment for inoperable HCC with prolonged survival and good life quality. Iodized oil uptake pattern can be considered a good prognostic marker.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11736709     DOI: 10.1080/028418501127347278

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.701


  10 in total

1.  Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  Yong-Song Guan; Xiao-Hua Zheng; Xiang-Ping Zhou; Juan Huang; Long Sun; Xian Chen; Xiao Li; Qing He
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

2.  Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.

Authors:  Fu-Hua Yan; Kang-Rong Zhou; Jie-Min Cheng; Jian-Hua Wang; Zhi-Ping Yan; Reng-Rong Da; Jia Fan; Yuan Ji
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

3.  Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study.

Authors:  Xin Li; Gan-Sheng Feng; Chuan-Sheng Zheng; Chen-Kai Zhuo; Xi Liu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

4.  Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma.

Authors:  Jun Qian; Jochen Truebenbach; Florian Graepler; Philippe Pereira; Peter Huppert; Thomas Eul; Gundula Wiemann; Claus Claussen
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

5.  Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma.

Authors:  Yi-Sheng Liu; Ming-Ching Ou; Yi-Shan Tsai; Xi-Zhang Lin; Chien-Kuo Wang; Hong-Ming Tsai; Ming-Tsung Chuang
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

6.  Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study.

Authors:  Lin Zheng; Chen-Yang Guo; Cheng-Shi Chen; Jin-Cheng Xiao; Hong-Tao Hu; Hong-Tao Cheng; Deng-Wei Zong; Li Jiang; Hai-Liang Li
Journal:  Oncotarget       Date:  2017-06-29

7.  DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot Study.

Authors:  Do Seon Song; Jong Young Choi; Sun Hong Yoo; Hee Yeon Kim; Myeong Jun Song; Si Hyun Bae; Seung Kew Yoon; Ho Jong Chun; Byung Gil Choi; Hae Giu Lee
Journal:  Gut Liver       Date:  2013-01-11       Impact factor: 4.519

Review 8.  Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.

Authors:  Hyun Young Woo; Jeong Heo
Journal:  Clin Mol Hepatol       Date:  2015-12-24

9.  Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.

Authors:  Cheng-Shi Chen; Fang-Kun Li; Chen-Yang Guo; Jin-Cheng Xiao; Hong-Tao Hu; Hong-Tao Cheng; Lin Zheng; Deng-Wei Zong; Jun-Li Ma; Li Jiang; Hai-Liang Li
Journal:  Oncotarget       Date:  2016-02-09

10.  Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.

Authors:  Yi-Sheng Liu; Chia-Ying Lin; Ming-Tsung Chuang; Chia-Ying Lin; Yi-Shan Tsai; Chien-Kuo Wang; Ming-Ching Ou
Journal:  BMC Gastroenterol       Date:  2018-08-03       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.